期刊文献+

基础胰岛素联合口服降糖药替换胰岛素泵治疗2型糖尿病患者的影响因素分析 预览

Analysis of influence factors of insulin combined with oral hypoglycemic agents replace insulin pump in the treatment of type 2 diabetes mellitus
在线阅读 下载PDF
分享 导出
摘要 目的研究在患者治疗过程中联合应用基础胰岛素与口服降糖药替换胰岛素泵的临床效果及其影响因素。方法按照治疗效果将2015年6月至2017年6月期间本院收治的380例2型糖尿病患者分为观察组与对照组各190例,对所有患者行基础胰岛素与口服降糖药联合应用替换胰岛素泵。结果在糖化血红蛋白、撤泵时餐后2 h血糖、基础胰岛素联合口服降糖药治疗时间及口服降糖药用量方面,差异无统计学意义(P〉0.05);而在病程时间、BMI、空腹C肽、餐后2 h C肽、撤泵时空腹血糖、撤泵时胰岛素总量、撤泵时胰岛素基础量、胰岛素泵治疗时间方面,差异有统计学意义(P〈0.05)。结论患者的病程时间、BMI、空腹C肽、餐后2 h C肽、撤泵时空腹血糖、撤泵时胰岛素总量、撤泵时胰岛素基础量及胰岛素泵治疗时间等方面均是影响基础胰岛素联合口服降糖药替换胰岛素泵治疗2型糖尿病临床效果的因素,决定了两种治疗方式能否成功转换。 Objective To study the clinical effect and influencing factors of insulin combined with oral hypoglycemic agents replace insulin pump in the treatment of type 2 diabetes mellitus.Methods According to the therapeutic effect,380 patients with type 2 diabetes mellitus treated in our hospital from June 2015 to June 2017 were divided into two groups,the effective group( n = 190) and the ineffective group( n = 190). The patients in effective group received the treatment of combination of insulin and oral hypoglycemic agents replace insulin pumps.Results There was no significant difference between the two groups in glycosylated hemoglobin,blood glucose two hours after meal,the treatment time of basal insulin combined with oral hypoglycemic drugs and dosage of oral hypoglycemic drugs( P〉0.05). The differences of course time,body mass index,fasting c peptide,c peptide two hours after meal,fasting blood glucose during withdrawal,total insulin during pump withdrawal,insulin base amount during pump withdrawal,treatment time of insulin pump between the two groups were statistically significant( P〈0.05).Conclusions The course time,body mass index,fasting c peptide,c peptide two hours after meal,fasting blood glucose during withdrawal,total insulin during pump withdrawal,insulin base amount during pump withdrawal,and treatment time of insulin pump were the influence factors for whether replace insulin pump in the treatment of type 2 diabetes mellitus.
作者 刘春梅 陈兰英 任佳伟 曹积萍 LIU Chun-mei. (Endocrinology department, the fourth people 's hospital of Taizhou, Taizhou, Jiangsu, 225300, China)
出处 《齐齐哈尔医学院学报》 2017年第21期2516-2517,共2页 Journal of Qiqihar Medical College
关键词 胰岛素 糖尿病 口服降糖药 blood glucose withdrawal pump withdrawal pump withdrawal insulin pump
  • 相关文献

参考文献4

二级参考文献25

  • 1中国医师协会内分泌代谢科医师分会,中华医学会内分泌.中国胰岛素泵治疗指南(2010)[J].中国医学前沿杂志(电子版),2011(4):78-86. 被引量:38
  • 2中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国糖尿病杂志,2012,20(1):1 -36. 被引量:394
  • 3Alten B.King. Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24h in patients with type 2 diabetes:a double-blind,randomized,crossover study[J].Diabetes,Obesity and Metabolism,2009.69-71. 被引量:1
  • 4Soran H,Younis N. Insulin detemir:a new basal insulin analogue[J].Diabetes,Obesity and Metabolism,2006.26-30. 被引量:1
  • 5Heise T,Pieber TR. Towaids peaklsss,reproducible and longacting insulins.An assessment of the basal analogues based on isoglycaemic clamp studies[J].Diabetes,Obesity and Metabolism,2007.648-659. 被引量:1
  • 6Rosenstock J,Davies M,Home PD. A randomized,52-week,treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabets[J].Diabetologia,2008.408-416. 被引量:1
  • 7Heise T,Eckers U,Kanc K. The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart:a randomized,glucose clamp,crossover study[J].Diabetes Technology and Therapeutics,2008.479-485. 被引量:1
  • 8ILKOVA H, GLASER B, TUNCKALE A, et al. Induction of long -term glycemic control in newly diagnosed type 2 diabetic patientsby transient intensive insulin treatment[ J]. Diabetes Care, 1997,20(9) :1353 -1356. 被引量:1
  • 9RYAN E A, IMES S, WALLACE C. Short - term intensive insulintherapy in newly diagnosed type 2 diabetes [ J ]. Diabetes Care,2004,27(5) : 1028 -1032. 被引量:1
  • 10LI Y B,XU W,LIAO Z,et al. Induction of long - term glycemiccontrol in newly diagnosed type 2 diabetic patients is associatedwith improvement of beta - cell function [ J ]. Diabetes Care,2004,27(11) : 2597 -2602. 被引量:1

共引文献37

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈